Effects of ginsenosides on electroencephalogram power spectra in rats
Fen‐Fang Hong, Gui-lin Tu, Zhaohui Wang, Dalei Zhang, Lei Wu, Bei Yang, Shu‐Long Yang
Abstract
Fen‐Fang Hong, Gui-lin Tu, Zhaohui Wang, Dalei Zhang, Lei Wu, Bei Yang, Shu‐Long Yang
Abstract
Aim: To investigate the effects of Ginsenosides (GS) on EEG power wave spectra of spontaneous sleep. Method: Adult SD rats were randomly divided into the control, GS 10 and 100 mg/kg groups. After recovery from operation, rats were orally administered GS 10 and 100 mg/kg or water once per day for 6 days. On day 1 and 6 of GS administration, Polygraphic signs of undisturbed sleep-wake activities were recorded for 12h after GS administration. Results: On GS administration day 1, 10 and 100 mg/kg GS enhanced θ power of NREM and wakefulness but reduced θ power of wakefulness and α power during sleep and wakefulness, 10 and 100mg/kg GS lowered θ power of NREM and REM stage, respectively. After 6 days of GS administration, 10 and 100mg/kg GS enhanced δ power during NREM and wakefulness but reduced θ power of wakefulness and α power during sleep and wake state, 10 mg/kg GS also lowered θ power of NREM. The increase of δ power in all stages, the decrease of α power in NREM and REM sleep and the decrease of α power during NREM and wakefulness were observed in 10mg/kg group; the decrease of θ power during NREM sleep and of α power during wakefulness and the increase of δ power in wakefulness shown in 100mg/kg group. Conclusion: These results demonstrate that GS can regulate extensively cortical EEG power spectra in rats.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Aim: To investigate the effects of Ginsenosides (GS) on EEG power wave spectra of spontaneous sleep. Method: Adult SD rats were randomly divided into the control, GS 10 and 100 mg/kg groups. After recovery from operation, rats were orally administered GS 10 and 100 mg/kg or water once per day for 6 days. On day 1 and 6 of GS administration, Polygraphic signs of undisturbed sleep-wake activities were recorded for 12h after GS administration. Results: On GS administration day 1, 10 and 100 mg/kg GS enhanced θ power of NREM and wakefulness but reduced θ power of wakefulness and α power during sleep and wakefulness, 10 and 100mg/kg GS lowered θ power of NREM and REM stage, respectively. After 6 days of GS administration, 10 and 100mg/kg GS enhanced δ power during NREM and wakefulness but reduced θ power of wakefulness and α power during sleep and wake state, 10 mg/kg GS also lowered θ power of NREM. The increase of δ power in all stages, the decrease of α power in NREM and REM sleep and the decrease of α power during NREM and wakefulness were observed in 10mg/kg group; the decrease of θ power during NREM sleep and of α power during wakefulness and the increase of δ power in wakefulness shown in 100mg/kg group. Conclusion: These results demonstrate that GS can regulate extensively cortical EEG power spectra in rats.
Key concepts: Wakefulness, Non-rapid eye movement sleep, Sleep (system call), Internal medicine, Anesthesia, Medicine, Psychology, Endocrinology